Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
ChrysCapital, one of the biggest private equity firms investing in India, acqui...
Targeting long non-coding ribonucleic acid (lncRNA), HTX-001 is being evaluated ...
The deal grants CORE Biomedicine rights to develop and commercialise a portfolio...
We keep telling ourselves the same story: India is the pharmacy of the world, a...
Dermatology has always occupied an unusual position in medicine — visible enoug...
ReNU syndrome is a rare neurodevelopmental disorder that is caused by variants i...
Approved by both companies’ boards of directors, the transaction is expected to ...
Cipla and its wholly owned subsidiary Cipla USA announced that it has received ...
Chandigarh Pharma Summit 2026 | 16th July 2026 The post Dr Sanjit Singh Lamba, ...
Chandigarh Pharma Summit 2026 | 16th July 2026 The post Prof. Krishan Gopal, NI...
Chandigarh Pharma Summit 2026 | 16th July 2026 The post Panel Discussion: Geopo...
Chandigarh Pharma Summit 2026 | 16th July 2026 The post Mr Priadarshan Singh, S...
Chandigarh Pharma Summit 2026 | 16th July 2026 The post Panel Discussion: From ...
Chandigarh Pharma Summit 2026 | 16th July 2026 The post Mr Abhinav Vikash, Head...
Chandigarh Pharma Summit 2026 | 16th July 2026 The post Mr Shivaji Chakraborty,...
Chandigarh Pharma Summit 2026 | 16th July 2026 The post Panel Discussion: India...